WebMasamitsu HarataFounder/Representative director/President/CEO at Human Life CORD Japan Inc. Masanori KobayashiSenior consultant at Deloitte Tohmatsu Consulting LLC Masaru YodaExecutive Officer, Head of Sales Development at INNOPHYS CO.,LTD. Masatoshi IshiiDeputy Director of Tokyo Metropolitan Government Web26 apr. 2024 · -Tissue Genesis LLC和Human Life CORD Japan, Inc.宣布達成獨家協議-內容為推動亞洲成年人幹細胞療法的發展-Tissue Genesis獲得專利的臨床級細胞療法處理解決方案將在中國與日本獲得授權並進行銷售,用於商業應用和醫療研究。 向醫療難題發起挑戰,再生醫學創企Fortuna完成2500萬美元B輪融資 2024-01-02 近日,再生醫療創 …
Masamitsu Harata on LinkedIn: TOP
http://www.independents.jp/article/item002236 WebWe are pleased to announce that Human Life CORD have entered into a joint commercialization agreement with Mochida pharmaceutical to develop and market ... prince\\u0027s-feather ya
Japan Biotech Startups Directory 2024-2024: Profiles of 395 …
Web採用について ヒューマンライフコード株式会社 Human Life CORD inc. 当社ミッション「臍帯由来間葉系細胞を一日も早く製品化し、その安定供給を通して難病で苦しむ患 … Web18 nov. 2024 · Human LifeCode, Inc. is a drug discovery bio-venture that prioritizes research and development for immune and inflammatory diseases, especially rare and … Web1mo Season's Greetings We really appreciate your kindness and support throughout this year. 2024 will be a pivotal year for Human Life CORD Japan Inc., which has been clinically developing a... prince\\u0027s-feather yi